March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Primary and Repeat Selective Laser Trabeculoplasty in Pseudophakic Eyes: 2 year follow-up
Author Affiliations & Notes
  • Tamara L. Berezina
    Ophthalmology, UMDNJ-New Jersey Medical School, Newark, New Jersey
  • Albert S. Khouri
    Ophthalmology, UMDNJ-New Jersey Medical School, Newark, New Jersey
  • Barry A. Maltzman
    Ophthalmology, UMDNJ-New Jersey Medical School, Newark, New Jersey
  • Khelly Shah
    Drexel University, Philadelphia, Pennsylvania
  • Robert D. Fechtner
    Ophthalmology, UMDNJ-New Jersey Medical School, Newark, New Jersey
  • Footnotes
    Commercial Relationships  Tamara L. Berezina, None; Albert S. Khouri, None; Barry A. Maltzman, None; Khelly Shah, None; Robert D. Fechtner, None
  • Footnotes
    Support  Research to Prevent Blindness, Inc., New York, The Glaucoma Research and Education Foundation, Inc., New Jersey, and an unrestricted gift from Joseph & Marguerite DiSepio.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5959. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tamara L. Berezina, Albert S. Khouri, Barry A. Maltzman, Khelly Shah, Robert D. Fechtner; Primary and Repeat Selective Laser Trabeculoplasty in Pseudophakic Eyes: 2 year follow-up. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5959.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To study the efficacy of selective laser trabeculoplasty (SLT) in pseudophakic eyes after primary and repeat SLT.

 
Methods:
 

Retrospective review of electronic medical records from affiliated practice of patients with open angle glaucoma who underwent primary (SLT I) and repeat (SLT II) 360-degree SLT for intraocular pressure (IOP) reduction between 06/2003 and 11/2007. Twenty three pseudophakic eyes from 18 patients who underwent cataract surgery at least six months prior to SLT I were included. Patients with history of any incisional ocular surgery other than cataract were excluded. The first age-matched 23 phakic eyes selected from the database served as controls. Demographic data, SLT parameters, IOP and number of glaucoma medications were collected at baseline and 1, 4, 8, 12, 18, and 24 months. Success of the procedure was defined as 20% reduction from baseline IOP. Mean, SD, one way ANOVA followed by Tukey's test, and chi-square (Χ2) test were used for analysis.

 
Results:
 

Age, race, SLT parameters in pseudophakic and phakic group were not statistically different. Pre-treatment IOP did not differ between groups (19.2±2.5 vs. 19.7±3.2 mmHg before SLTI, P>0.05; 19.2±3.4 vs. 18.9±4.6 mmHg before SLT II, p>0.05). Mean numbers of glaucoma medications did not change during 24 month follow-up in both groups. Percentage of pseudophakic and phakic eyes achieving ≥20% IOP reduction did not statistically differ after primary and repeat SLT up to 24 months (Table).

 
Conclusions:
 

Percentage of successful IOP reduction from primary and repeat SLT in pseudophakic eyes was not significantly different from phakic eyes. These retrospective data suggest primary and repeat SLT were similarly effective in phakic and pseudophakic eyes.  

 
Keywords: intraocular pressure • laser • clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×